Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/13423
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIkram, Huma-
dc.contributor.authorAtique, Iqra-
dc.contributor.authorPerveen, Shahla-
dc.contributor.authorZakir, Rumaisa-
dc.contributor.authorHaleem, Darakhshan J-
dc.date.accessioned2022-10-20T09:54:55Z-
dc.date.available2022-10-20T09:54:55Z-
dc.date.issued2021-01-16-
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/13423-
dc.description.abstractPresent study was designed to monitor the dose dependent effects of lorazepam; a benzodiazepine (CNS depressant). It is the primary drug of choice for treatment of anxiety and to produce calming effects. However, repeated administration of this lorazepam causes dependence and this might be caused by increased dopaminergic neurotransmission. Besides dopamine, 5-hydroxy tryptamine (5-HT) has also been reported to have pivotal role in the pathophysiology as well as treatment of anxiety and addiction. Repeated administration of lorazepam might involve altered 5-HT metabolism as well. Present study was therefore designed to monitor dose-dependent effects of lorazepam and to select its optimum dose for further experiments and pharmacological interventions. Effects of lorazepam were monitored on food intake, growth rate, activities in familiar and novel environments, light dark box activity, forced swim test and metabolism of dopamine and 5-HT. oral administration of lorazepam was done at the doses of 0mg/kg, 2mg/kg, 4mg/kg and 6mg/kg. Behaviors parameters were monitored following single administration of lorazepam. Rats were decapitated and whole brain samples were collected and stored at -70°C until neurochemical analysis by HPLC-EC. Findings from the present study could be implicated to increased therapeutic utility of lorazepam and related benzodiazepines.en_US
dc.language.isoenen_US
dc.publisherKarachi: Faculty of Pharmacy & Pharmaceutical Sciecnes, University of Karachien_US
dc.subjectLorazepamen_US
dc.subjectAtivanen_US
dc.subjectlight dark box activityen_US
dc.subjectanxietyen_US
dc.subjectforced swim testen_US
dc.titleNeurochemical and behavioral effects of lorazepam: A dose related studyen_US
dc.typeArticleen_US
Appears in Collections:Issue 01

Files in This Item:
File Description SizeFormat 
Paper-18.htm131 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.